Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1475 | 0.780 | 0.077 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2007 | 2007 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 1998 | |||||||||
|
long intergenic non-protein coding RNA 1193 | 0.565 | 0.692 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2014 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 | 0.612 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2016 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2019 | |||||||||
|
microRNA 125a | 0.480 | 0.769 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2016 | 2016 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2017 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
defensin beta 103A | 0.573 | 0.731 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2004 | 2013 | |||||||||
|
microRNA 375 | 0.476 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | |||||||||
|
defensin beta 103B | 0.572 | 0.731 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2004 | 2013 | |||||||||
|
long intergenic non-protein coding RNA 598 | 0.743 | 0.192 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2015 | 2016 | |||||||||
|
small Cajal body-specific RNA 5 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2010 | 2013 | |||||||||
|
defensin alpha 1B | 0.674 | 0.692 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | |||||||||
|
RNA, 28S ribosomal N5 | 0.705 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
organic cation transporter 3 | 0.805 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
psoriasis susceptibility 1 candidate 3 | 0.769 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
Inflammatory bowel disease 19 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
Inflammatory bowel disease-15 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
Inflammatory bowel disease-18 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 |